Mechanistically, GClnc1 could interact with the complex of WDR5 (a key component of histone methyltransferase complex) and KAT2A histone acetyltransferase, leading to an alteration of the target gene histone modification pattern and thus enhancing the progression of GC. Here, SOD2 is linked to gastric cancer.